1. Introduction {#sec1}
===============

The need for in vitro physiological models and for clinical therapies has driven the development of synthetic biomaterials that recapitulate key features of the extracellular matrix (ECM).^[@ref1]^ Polymer hydrogels are an attractive foundation for synthetic ECM, as their biophysical and biochemical properties can be tuned in modular fashion to control cellular phenotype. Hydrogels built from macromers containing highly flexible, hydrophilic poly(ethylene glycol) (PEG) have found especially widespread use due to their biocompatibility, relative inertness to nonspecific cell interactions, relative ease of functionalization with biomolecular motifs, and commercial availability of reactive PEG macromers of various molecular weights and branching configurations.^[@ref2]−[@ref5]^ However, unmodified PEG hydrogels possess limited or no intrinsic biological function and thus may fail to support desired cell behaviors.

Many strategies have been explored to modify PEG hydrogels with ECM-derived biological cues such as adhesion peptides and growth factors,^[@ref6]−[@ref9]^ but facile, site-specific attachment of large peptides and proteins in a way that retains bioactivity remains a challenge, particularly if the approaches are intended to be used in the presence of cells. Photopolymerization and conjugation of peptides or proteins through amine groups^[@ref10]−[@ref14]^ are straightforward, but lack specificity and may alter protein function. Conjugation through click chemistry allows increased intermediate stability and improved efficiency of hydrogel conjugation; however, this approach is limited by the difficulties associated with producing proteins that incorporate precursors for click chemistry in an appropriate site-specific manner.^[@ref9]^

Here, we describe the use of sortase-mediated ligation of epidermal growth factor (EGF) to PEG-based synthetic ECM hydrogels. Sortases are transpeptidases found in Gram-positive bacteria, which anchor surface proteins to the bacterial cell wall in vivo.^[@ref15]^ The enzyme sortase A from *Staphylococcus aureus* recognizes a specific LPXTG motif (X = any amino acid except proline), cleaves the amide bond between the threonine and the glycine, and covalently attaches an oligoglycine nucleophile.^[@ref16]^ Moreover, the formed product maintains the LPXTG motif, allowing controlled release or cleavage of the tethered protein through a second sortase-mediated transpeptidase reaction in the presence of a soluble N-terminal oligoglycine nucleophile (e.g., triglycine, GGG).

Sortase-mediated ligation has found numerous applications in purification, modification and immobilization of proteins.^[@ref17],[@ref18]^ It has been used to conjugate proteins to different types of surfaces,^[@ref19]−[@ref27]^ liposomes^[@ref28]^ and peptides.^[@ref29],[@ref30]^ Here we extend sortase-mediated ligation to the modification of synthetic ECM hydrogels. Compared to other enzymatic approaches,^[@ref31]^ sortase-mediated ligation offers the advantage of enhanced catalytic rate due to the engineering of mutant sortases,^[@ref32]^ enhanced diffusion rate due to the relatively small size of the sortase (23.5 kDa), high yield of recombinant expression and relatively modest propensity to modify known mammalian proteins.^[@ref33]^

In this study, we ligated EGF to relatively soft, permeable PEG hydrogels prefunctionalized with cell adhesion motifs. The biophysical and cell adhesion properties of hydrogels were designed to support physiological culture of primary human epithelial cells. We formed hydrogels by copolymerizing acrylate-terminated multiarm PEG with a thiol-terminated *LPRTG* peptide and thiol-terminated multiarm PEG through Michael-type addition ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) as reported earlier.^[@ref3]^ This cross-linking was carried out in the presence of a cell adhesion peptide bearing a thiol reactive group to render the resulting hydrogels adhesive to primary human epithelial cells. An evolved triple mutant of the sortase A enzyme (P94S/D160N/K196T) developed by Liu and co-workers^[@ref32]^ was used to tether the previously reported N-terminal Gly~3~-tagged human epidermal growth factor (GGG-*EGF*)^[@ref30]^ to the hydrogel ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Characterization of the system included sortase-mediated cleavage of the tethered EGF for quantification in solution. To test the bioactivity of the tethered EGF, we investigated DNA synthesis with EGF-responsive human cryopreserved hepatocytes and primary human endometrial epithelial cells. Our results illustrate several features of the sortase-mediated ligation reaction as implemented for modification of synthetic ECM hydrogels, including the ability to efficiently release tethered proteins via a sortase-mediated reaction with a small soluble oligoglycine substrate, GGG.

![Process Used to Tether GGG-*EGF* to the Hydrogel\
Top: Hydrogels are formed by Michael-type additions of 8-arm PEG-acrylate stars cross-linked with 4-arm PEG-thiol stars. Adhesion peptides (SynKRGD) and sortase motif peptides (LPRTG) can also be cross-linked into the hydrogel if they contain a cysteine residue to react with the acrylate of the 8-arm PEG star. Bottom: (A) Sortase-mediated ligation of GGG-*EGF* to pre-formed PEG hydrogels containing *LPRTG* peptide. (B) Sortase diffuses into the hydrogel, cleaves the peptide bond between the threonine and the glycine of the *LPRTG* peptide, releasing G, then the N-terminus of GGG-*EGF*, which has diffused into the hydrogel, is ligated to the C-terminus of the LPRT-motif (C). The same sequence of steps can be used to cleave EGF once it is ligated to the hydrogel, by adding sortase and the simple peptide GGG; GGG will displace tethered EGF, releasing it into solution.](bm-2015-005498_0007){#sch1}

2. Experimental Section {#sec2}
=======================

2.1. Materials {#sec2.1}
--------------

Commercially available chemicals, including triglycine (GGG), were purchased from Sigma-Aldrich and used without further purification unless otherwise noted. PEG macromers (10 kDa 8-arm PEG-acrylate and 5 kDa 4-arm PEG-thiol) were purchased from JenKem. All custom peptides were synthesized by Boston Open Laboratories, USA, as follows: Ac-CRGLPRTGG-CONH~2~ (*LPRTG*), Ac-CRGLPRTGGK(ε-fluorescein)-CONH~2~ (*LPRTG*-fam), PHSRNGGGK(εGGG ERCG-Ac)-GG**RGD**SPY (*synKRGD*) and PHSRNGGGK(εGGGERCG-Ac)-GG**RDG**SPY (scrambled *synKRDG*). Hydrogels were formed in 96-well angiogenesis plates (0.125 cm^2^; Ibidi). The recombinant sortaggable GGG-*EGF* (human EGF fused to a triglycine sequence at the N-terminus) and the evolved triple mutant (P94S/D160N/D165A) of the sortase A enzyme^[@ref32]^ were expressed and purified as previously reported.^[@ref30]^ Reagents from the DuoSet EGF ELISA kit (R&D Systems, DY236-05) were used for EGF detection. Cryopreserved hepatocytes (Human Plateable Hepatocytes, Induction Qualified, lot\# Hu1663) and hepatocyte media were purchased from Life Technologies. Human wild type EGF (hEGF) was obtained from Invitrogen (PHG0313).

2.2. Hydrogel Fabrication and Sortase-Mediated Ligation of GGG-*EGF* {#sec2.2}
--------------------------------------------------------------------

Using Michael-type addition as described earlier^[@ref3]^ nominal (preswelling) 5% *w/v* polymer hydrogels with 1:1 thiol:acrylate ratio were synthesized by preincubating PEG-acrylate macromers with *LPRTG* and adhesion peptides in phosphate buffered saline (PBS) at pH 6.9 for 20 min. Adhesion peptides (*synKRGD* or scrambled *synKRDG*) were added at a nominal concentration of 500 μM and *LPRTG* nominal concentrations varied from 0 to 250 μM. PEG-thiol cross-linking macromers were added and 10 μL hydrogels were formed within the inner wells of a 96-well angiogenesis plate. After gelation \[around 1 h at room temperature (RT)\], hydrogels were covered with PBS and allowed to swell for 90 min at 4 °C with PBS changes every 30 min. They were further allowed to swell in intermediate buffer (50 mM HEPES, 150 mM NaCl, pH 7.9) for 90 min at 4 °C with buffer changes every 30 min. Hydrogels were blocked with 70 μL/well calcium buffer (50 mM HEPES, 150 mM NaCl, 10 mM CaCl~2~, pH 7.9) containing 0.5% purified bovine casein for 1 h at RT. Tethering solution containing 2 or 20 μM GGG-*EGF* and 15 μM sortase enzyme in calcium buffer was added to the hydrogels (50 μL per well) and the reaction was allowed to proceed for 1 h at RT with constant agitation at 30 rpm. Tethering solution without sortase was used to test for nonspecific binding of GGG-*EGF* to hydrogels and calcium buffer was used for control and in soluble EGF conditions. The sortase reaction was stopped by addition of 5 μL/well of ethylenediaminetetraacetic acid (EDTA; 300 mM), then supernatants were collected and frozen at −80 °C for EGF quantification, and hydrogels were extensively washed (3× immediately and every 30 min for 3 h) with 70 μL/well intermediate buffer and soaked overnight at 4 °C.

2.3. Hydrogel Fluorescence Measurements for Quantification of Incorporated or Sortase-Cleaved *LPRTG* {#sec2.3}
-----------------------------------------------------------------------------------------------------

Hydrogels containing a mix of 96% *LPRTG* and 4% *LPRTG*-fam peptides with varying total nominal peptide concentrations of 0, 20, 50, 100, or 250 μM were cross-linked in 96-well angiogenesis plates as described above. After 6 × 30 min washes at 4 °C, intermediate buffer (50 μL) was added on top of each hydrogel and fluorescence (λ~ex~ = 485 nm; λ~em~ = 530 nm) was measured using a microplate reader (SpectraMax M2^*e*^, Molecular Devices). A linear standard curve was established by measuring the fluorescence of hydrogels containing 0, 20, 50, 100, or 250 μM of total *LPRTG* peptide ([Supporting Information Figure 1](#notes-1){ref-type="notes"}). After incubation for 1 h with either 2 μM or 20 μM GGG-*EGF* in the presence of 15 μM sortase the reaction was stopped with 5 μL/well EDTA (300 mM) and hydrogels were extensively washed (3× immediately, every 30 min for 3 h and soaked overnight at 4 °C) before fluorescence reading. In order to correct for photobleaching, decreased fluorescence of control hydrogels was measured in the absence of sortase ([Supporting Information Figure 2](#notes-1){ref-type="notes"}).

2.4. GGG-*EGF* Detection via Direct ELISA on Hydrogels {#sec2.4}
------------------------------------------------------

Hydrogels were blocked with Odyssey Blocking Buffer (Li-Cor Biosciences) diluted 1:1 with PBS (OBB-PBS) for 1 h at RT and washed 3× with 0.1% Tween-20 in PBS. Hydrogels were incubated with biotinylated goat antihuman EGF detection antibody at a concentration of 50 ng/mL in OBB-PBS for 2 h at RT with constant agitation at 30 rpm. The washing steps were repeated and hydrogels were incubated with streptavidin-HRP diluted 1:40 in OBB-PBS for 20 min at RT with constant agitation at 30 rpm and protected from light. After washes, hydrogels were incubated with substrate solution consisting of a 1:1 mixture of Color Reagent A (H~2~O~2~) and Color Reagent B (tetramethylbenzidine) (R&D Systems, DY994) for 20--30 min at RT protected from light. The reaction was stopped with 1 M H~2~SO~4~. Aliquots (20 μL) of supernatant were transferred to a clear bottom Nunc MaxiSorp 384-well plate (Thermo Scientific) and absorbance at 450 nm was measured using a microplate reader (SpectraMax M2^*e*^, Molecular Devices). Absorbance at 540 nm was subtracted to account for optical imperfections of the plate.

2.5. Quantification of Sortase-Mediated Cleavage of Tethered EGF from Hydrogels {#sec2.5}
-------------------------------------------------------------------------------

A modified sandwich ELISA was used to measure the amount of EGF cleaved from hydrogels in the presence of sortase A and GGG peptide. GGG-*EGF*-tethered hydrogels were soaked in calcium buffer for 1 h at 4 °C and incubated for 48 h at 4 °C with constant agitation in 50 μL/well cleavage solution containing 20 mM GGG and 200 μM sortase in calcium buffer. Supernatants were collected and frozen. A clear bottom Nunc MaxiSorp 384-well plate (Thermo Scientific) was coated with mouse antihuman EGF capture antibody diluted at the recommended concentration of 4.0 μg/mL in sterile PBS. The plate was covered with an adhesive strip, spun at 1500 rpm for 3 min and incubated overnight at 4 °C with constant agitation. Three washing steps with 100 μL/well 0.1% Tween-20 in PBS were performed at RT using an automatic plate washer (405 Touch Microplate Washer, BioTek). The plate was blocked with 100 μL/well OBB-PBS and incubated for 2 to 6 h at RT with constant agitation at 30 rpm. Samples were first diluted with calcium buffer containing 1% BSA in 1.5 mL Protein LoBind tubes (Eppendorf) and then serially diluted in 0.5 mL Protein LoBind tubes. Standard curves were made by serially diluting GGG-*EGF* in 1% BSA in calcium buffer. After the washing steps, samples were plated and the plate was covered with an adhesive strip, spun at 1500 rpm for 3 min and incubated for 2 h at RT with constant agitation. This process was repeated with the biotinylated goat antihuman EGF detection antibody diluted at the recommended working concentration of 50 ng/mL in OBB-PBS. The plate was washed, incubated with streptavidin-HRP diluted 1:40 in OBB-PBS and spun at 1500 rpm for 3 min protected from light. After 20 min incubation at RT with constant agitation, the plate was washed and incubated with substrate solution for 20--30 min at RT protected from light. The reaction was stopped with 1 M H~2~SO~4~ and absorbance at 450 nm was measured.

2.6. Human Cryopreserved Hepatocyte Culture on Hydrogels {#sec2.6}
--------------------------------------------------------

After a PBS wash and UV-sterilization, hydrogels were soaked in human hepatocyte seeding medium (hHSM; Williams E medium supplemented with 5% FBS, 1 μM hydrocortisone, 1% penicillin/streptomycin (P/S), 4 μg/mL human recombinant insulin, 2 mM GlutaMAX, 15 mM HEPES (pH 7.4); CM3000) with or without 20 ng/mL hEGF for 1 h. Cryopreserved hepatocytes were quickly thawed in a 37 °C water bath, transferred into a 50 mL falcon tube with 25 mL prewarmed Cryopreserved Hepatocyte Recovery Medium (CHRM; CM7000) and centrifuged at RT at 100*g* for 8 min. Warm hHSM (1 mL) was added to the cell pellet and cells were gently rocked, counted (Countess Cell Counter, Invitrogen) and placed on ice. Hepatocytes were seeded on hydrogels and on collagen I-coated (BioCoat, BD Biosciences) wells in 96-well angiogenesis plates at a density of 60 000 cells/cm^2^ (7500 cells/well) in 50 μL/well hHSM. Hepatocytes were incubated at 37 °C, 95% air, 5% CO~2~. Twenty-four hours after cell seeding, medium was switched to serum-free human hepatocyte maintenance medium (hHMM; Williams E medium supplemented with 0.1 μM hydrocortisone, 0.5% P/S, ITS+ (human recombinant insulin (6.25 μg/mL), human transferrin (6.25 μg/mL), selenous acid (6.25 ng/mL), bovine serum albumin (1.25 mg/mL), linoleic acid (5.35 μg/mL)), 2 mM GlutaMAX, 15 mM HEPES (pH 7.4); CM4000) with or without 20 ng/mL hEGF and cells were incubated for 24 h.

2.7. Endometrial Biopsy Collection and Isolation {#sec2.7}
------------------------------------------------

Eutopic endometrial biopsies were obtained from two premenopausal women in the proliferative phase of the menstrual cycle, who were undergoing surgery for benign gynecological diseases. Selective criteria included that the patients had regular menstrual cycles (26 to 35 days) and were not using hormonal treatment for at least 3 months prior to surgery. A standardized questionnaire was used to document all clinical data. Tissues were collected with the approval of the Partners Human Research Committee and the Massachusetts Institute of Technology Committee on the Use of Humans as Experimental Subjects and with the informed consent of each patient. Endometrial Pipelle biopsies were dissociated and cells purified as described by Osteen and co-workers^[@ref34]^ with some modifications ([Supporting Information](#notes-1){ref-type="notes"}).

2.8. Endometrial Epithelial Cell Culture on Hydrogels {#sec2.8}
-----------------------------------------------------

Before cell seeding, hydrogels were washed with PBS, UV-sterilized for 15 min and soaked in DMEM/F12/FBS (mixture of Dulbecco's Modified Eagle's Medium and Ham's F-12 (Gibco) supplemented with 1% penicillin/streptomycin and 10% *v*/*v* dextran/charcoal treated fetal bovine serum (Atlanta Biologicals) with or without 20 ng/mL hEGF for 1 h. Cultured endometrial epithelial cells (EECs) were trypsinized and seeded on hydrogels and on standard tissue-culture polystyrene (TCPS) in 96-well angiogenesis plates at a density of 20 000 cells/cm^2^ (2500 cells/well) in 50 μL/well DMEM/F12/FBS. EECs were incubated at 37 °C, 95% air, 5% CO~2~. Twenty-four hours after cell seeding, medium was switched to serum-free medium DMEM/F12 with or without 20 ng/mL hEGF and cells were incubated for 16 h.

2.9. DNA Synthesis Assay {#sec2.9}
------------------------

Click-iT EdU Alexa Fluor 488 kit (Life Technologies) was used to quantify cells actively synthesizing DNA. Forty-eight hours after cell seeding, hepatocytes were incubated in hHMM with 10 μM of 5-ethynyl-2′-deoxyuridine (EdU) in with or without 20 ng/mL (3.3 nM) hEGF for 24 h at 37 °C, 95% air, 5% CO~2~. Similarly, EECs were incubated 40 h post seeding with 10 μM EdU in DMEM/F12 with or without 20 ng/mL (3.3 nM) hEGF for 24 h. Both cell-types were fixed with 3.7% formaldehyde in PBS for 15 min at RT. Cells were washed twice with 3% BSA in PBS and permeabilized with 0.5% Triton X-100 in PBS for 20 min at RT. Click-iT reaction cocktail was prepared as described by the manufacturer and 20 μL per well was added. Cells were incubated for 30 min at RT protected from light. After cells were washed once with 3% BSA in PBS and once with PBS, they were incubated with Hoechst 33342 diluted 1:2000 in PBS for 30 min at RT protected from light. Cells were finally washed twice with PBS and imaged using a Leica DMI 6000 microscope and Oasis Surveyor software. Images were processed, and cell nuclei were counted using ImageJ64 software. The percentage of cells synthesizing DNA was computed as the ratio of cells positively stained with Alexa Fluor 488 divided by the total number of cells given by Hoechst counter-staining.

3. Results and Discussion {#sec3}
=========================

We first evaluated the ability of the evolved triple mutant of the sortase A to tether the solution-phase GGG-*EGF* nucleophile to *LPRTG* substrate motifs that were covalently incorporated in PEG hydrogels (*LPRTG*-gel). Compared to the wild-type sortase, this mutant displays a 3-fold improvement in turnover (*k*~cat~ = 4.8 ± 0.6 s^--1^) and a 14-fold improvement in the affinity for the LPXTG substrate (*K*~m LPXTG~ = 0.56 ± 0.007 mM), resulting in a 43-fold increase of catalytic efficiency (*k*~cat~/K~m LPXTG~ = 8600 ± 1500 M^--1^ s^--1^), although the affinity for the N-terminal GGG substrate is less favorable.^[@ref32]^ These enhanced properties were predicted to allow efficient catalysis at the relatively low LPXTG substrate concentrations in the hydrogels.

Sortase-mediated ligation was characterized by three complementary methods: measurement of the consumption of the GGG-*EGF* nucleophile from the reaction solution, measurement of the consumption of the *LPRTG-*gel substrate, and measurement of GGG-*EGF* released from the hydrogel after sortase-mediated cleavage of tethered EGF from the hydrogel. We also used a direct on-gel ELISA approach to assess EGF accessibility. The results of these experiments were used to define suitable tethering conditions to create synthetic ECM for modulation of epithelial cell DNA synthesis.

3.1. The Amount of GGG-*EGF* Consumed from Solution in the Presence of Sortase Depends on *LPRTG*-Gel Concentration {#sec3.1}
-------------------------------------------------------------------------------------------------------------------

We first measured the disappearance of the GGG-*EGF* nucleophile from the supernatants of PEG hydrogels fabricated with systematically varied *LPRTG-*gel concentrations (0, 20, 50, 100, or 250 μM, corresponding to 0, 200, 500, 1000, and 2500 total pmol *LPRTG* per hydrogel) and then exposed to coupling solutions containing 15 μM (750 pmol) sortase and GGG-*EGF* at concentrations of either 2 μM (100 pmol total peptide) or 20 μM (1000 pmol total peptide) to tether EGF via [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. The amount of GGG-*EGF* present in the reaction supernatant was measured by sandwich ELISA at the start and end of the reaction.

For control hydrogels (i.e., *LPRTG-*gel = 0 μM), GGG-*EGF* diffuses into the hydrogel but does not react even in the presence of sortase. The observed reduction in GGG*-EGF* concentration in the supernatant of control hydrogels due to this partitioning was 6% for both the 2 and 20 μM GGG-*EGF* conditions ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A,B), a value about half that expected based on simple dilution due to the volume of liquid in the hydrogel and consistent with the protein-repulsion properties of PEG. For both the 2 μM and 20 μM GGG-*EGF* coupling concentrations, GGG-*EGF* depletion from the coupling solution increased with increasing concentrations of *LPRTG-*gel ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A,B) in a manner consistent with enzyme catalysis of the reaction. For the 2 μM GGG-*EGF* coupling condition ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A), total *LPRTG*-gel is always in stoichiometric excess to total GGG-*EGF* (200--2500 pmol *LPRTG*: 100 pmol GGG-*EGF*); hence, the incomplete depletion of GGG-*EGF* substrate (∼20% at each condition) indicates a kinetic or thermodynamic limit to coupling under these conditions. Interestingly, for the 20 μM GGG-*EGF* coupling condition ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B), the proportion of GGG-*EGF* depleted for each *LRPTG-*gel concentration is comparable to that in the 2 μM GGG-*EGF* case; i.e., within the error of the ELISA, 10 times as much GGG-*EGF* is consumed in the 20 μM versus 2 μM GGG-*EGF* coupling condition ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A,B).

![Amount of GGG-*EGF* peptide nucleophile remaining in solution as a function of total *LPRTG* concentration in hydrogel. GGG-*EGF* is quantified by sandwich ELISA before and after sortase-mediated ligation of GGG-*EGF* to preformed hydrogels containing *LPRTG*, using nucleophile concentrations of 2 μM (A) or 20 μM (B). The amount of GGG-*EGF* remaining in solution after sortase-mediated ligation decreases with increasing *LPRTG* concentration in hydrogel. Error bars represent standard error of the mean (*n* = 2).](bm-2015-005498_0001){#fig1}

This apparent first-order dependence of the reaction on GGG-*EGF* concentration is consistent with the reported ping-pong bibi mechanism for sortase A,^[@ref35]^ where a thioacyl intermediate is resolved by the N-terminus of an oligoglycine nucleophile---provided that there is sufficient oligoglycine to render the competing reaction, hydrolysis,^[@ref16]^ relatively unimportant. However, the interpretation of the results from this pilot experiment is inherently limited by the convolution of two rate processes---enzyme kinetics and enzyme/substrate diffusion---occurring simultaneously with a complex reaction mechanism, which can include not only ligation but also hydrolysis. Based on size, the diffusion coefficients of GGG-*EGF* and sortase in water are about 2.5 × 10^--6^ cm^2^/s and 1.5 × 10^--6^ cm^2^/s, respectively,^[@ref36]^ and diffusion of molecules of this size in the hydrogels would be expected to be hindered by 50--90%.^[@ref36]−[@ref38]^ We can thus estimate the characteristic diffusion times, τ~D~, for GGG-*EGF* and sortase in the hydrogel in the absence of reaction as 0.4--1.8 h and 0.6--3 h, respectively, using the well-established relationship τ~D~ ∼ *L*^2^/4*D*~A-hydrogel~ where *L* is the thickness of the hydrogel (0.8 mm) and *D*~A-hydrogel~ is the effective diffusion coefficient for either GGG-*EGF* or sortase in the hydrogel. These characteristic diffusion times represent a lower boundary, as interactions with the *LPRTG-*gel substrate would be expected to retard diffusion and create gradients in reaction rate during the 1 h incubation. In summary, this pilot experiment provides compelling evidence that sortase is capable of tethering relatively large peptides (∼6 kDa) to PEG hydrogels, motivating further characterization of the reaction process.

3.2. *LPRTG* Cleavage Product Is Released from the Hydrogel in the Presence of GGG-*EGF* and Sortase {#sec3.2}
----------------------------------------------------------------------------------------------------

In order to elucidate how many *LPRTG* molecules were effectively processed by sortase, 4% of the *LPRTG* peptides incorporated into the hydrogels were labeled with fluorescein (*LPRTG*-fam). When the sortase enzyme cleaves the peptide bond between the threonine and the glycine of the *LPRTG*-fam motif, fluorescein is released, thus resulting in a decrease of fluorescence associated with the hydrogel. Fluorescence intensities after washing for hydrogels before and after incubation for 1 h with either 2 μM or 20 μM GGG-*EGF* in the presence or absence of 15 μM sortase are shown in [Supporting Information Figure 2](#notes-1){ref-type="notes"}. After correction for photobleaching, fluorescence intensities were converted to pmol *LPRTG* in hydrogel (see [Experimental Section](#sec2){ref-type="other"}), and the amount of reacted *LPRTG* was calculated as the difference between the values before and after the sortase reaction. As shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, *LPRTG* consumption increased with increasing initial amount of *LPRTG* in the hydrogels and was greater for the 20 μM GGG-*EGF* than the 2 μM GGG-*EGF* condition. This pattern is qualitatively consistent with the trends seen for consumption of GGG-*EGF* ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). This confirms that the triple mutant sortase is capable of recognizing the *LPRTG* motif when it is incorporated in PEG hydrogels; i.e., sortase can cleave the peptide bond between the threonine and the glycine in order to release the fluorescein from the hydrogel.

![Amount of reacted *LPRTG* as a function of total initial *LPRTG* amount in hydrogel. After correction for photobleaching, fluorescence intensities were converted to pmol *LPRTG* in the hydrogel and the amount of reacted *LPRTG* was calculated as the difference between the values before and after sortase-mediated ligation. Error bars represent standard error of the mean (*n* = 2).](bm-2015-005498_0002){#fig2}

Interestingly, whereas the amount of GGG-*EGF* consumed from the supernatant in the 20 μM condition was 10-fold higher than the amount consumed in the 2 μM condition, the amount of reacted *LPRTG* at the 20 μM GGG-*EGF* condition was only about 2-fold higher than the reacted *LPRTG* at the 2 μM condition ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). We speculate that this discrepancy arises from a difference in the relative rates of hydrolysis and transpeptidation for the different GGG-*EGF* concentrations. Considering the greatest *LPRTG* concentration as a representative case, the number of moles of GGG-*EGF* consumed (20 pmol and 230 pmol for the 2 μM and 20 μM concentrations, respectively) is substantially lower than the amount of reacted *LPRTG* (140 pmol and 310 pmol for the 2 μM and 20 μM GGG-*EGF* concentrations, respectively), and the ratio of reacted *LPRTG*:GGG-*EGF* consumed is much higher for the lower GGG-*EGF* concentration. Because the sortase and *LPRTG* concentrations compared here are identical and only the GGG-*EGF* nucleophile concentration changes, this observation is consistent with nucleophile starvation at the lower GGG-*EGF* concentration leading to proportionately greater hydrolysis compared to ligation. This interpretation is plausible as the *K*~m,GGG~ value is in the millimolar range, and thus the reaction would be expected to be in a regime that depends on the GGG-*EGF* concentration.

3.3. Specific Tethering of GGG-*EGF* Increases with *LPRTG* Concentration in Hydrogels and GGG-*EGF* Concentration in Solution {#sec3.3}
------------------------------------------------------------------------------------------------------------------------------

A noteworthy aspect of sortase-mediated ligation is that the product formed contains an LPRTGGG sequence that becomes itself a potential substrate if a GGG-containing nucleophile is available. During ligation of GGG-*EGF* to the hydrogel through the *LPRTG* motif covalently incorporated into the hydrogel, this secondary reaction is minimized by the presence of a substantial stoichiometric excess of *LPRTG* substrate compared to GGG-*EGF.* However, this feature can also be exploited to cleave EGF from the hydrogel following ligation, by adding a high concentration (20 mM) of the simple nucleophile *GGG*, thus driving the reaction toward replacement of EGF by GGG and freeing EGF to the solution phase. Subsequent measurement of EGF in solution via ELISA allows the amount of ligated (vs nonspecifically associated) EGF to be ascertained.

In order to establish reaction conditions that would lead to complete cleavage of the tethered molecules, we used cleavage of *LPRTG*-fam as a surrogate measure for reaction progress. As noted above, sortase-mediated reactions occurring in the hydrogel require diffusion of the enzyme and substrate into the hydrogel, a process that likely requires several hours longer than the 1 h reaction time used for ligation. After the initial ligation reaction with 2 or 20 μM GGG-*EGF*, hydrogels containing 0, 20, 50, 100, or 250 μM of total *LPRTG*-containing peptide at a ratio of 4% *LPRTG*-fam and 96% *LPRTG* were incubated with 20 mM GGG and 200 μM sortase for 48 h at 4 °C. Fluorescence was measured as previously described. After this cleavage step (i.e., cleavage of previously tethered GGG-*EGF* plus *LPRTG* and *LPRTG*-fam), the percentage of residual fluorescence dropped to a similar level of 9--12% of initial fluorescence for all *LPRTG* concentrations and for both GGG-*EGF* concentrations ([Supporting Information Figure 3](#notes-1){ref-type="notes"}). Residual fluorescence is likely caused by adsorption of fluorescein to the plastic of the plate or to the hydrogel, or less likely, by inaccessibility of certain *LPRTG*-fam molecules to cleavage. The relatively similar low level of residual fluorescence observed for all the conditions suggests that previously tethered GGG-*EGF* was released completely.

![Amount of GGG-*EGF* released in solution as a function of total *LPRTG* concentration in hydrogel. GGG-*EGF* is quantified by sandwich ELISA after hydrogel washes and sortase-mediated hydrogel cleavage following tethering of GGG-*EGF* at either 2 μM (A) or 20 μM (B). The amount of GGG-*EGF* released in solution after sortase-mediated cleavage increases with increasing *LPRTG* concentration in hydrogel. Error bars represent standard error of the mean (*n* = 2).](bm-2015-005498_0003){#fig3}

Hydrogel supernatants were collected after all reaction steps, including washes following sortase-mediated ligation and after hydrogel cleavage, in order to quantify GGG-*EGF* with sandwich ELISA. [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} shows the amount of released GGG-*EGF* as a function of *LPRTG* concentration for sortase-mediated ligation at 2 and 20 μM GGG-*EGF* respectively. For both concentrations, the amount of GGG-*EGF* released during washes after tethering is low, constant, and proportional to the initial concentration of GGG-*EGF* used ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Cleaved EGF increased with *LPRTG* concentration in the hydrogels and is also proportional to the GGG-*EGF* in the initial tethering solution, a trend consistent with previous experiments. The sum of the amounts of GGG-*EGF* left in solution after ligation, extracted in washes, and released by cleavage should be equal to the amount of GGG-*EGF* present in the original coupling solution. Indeed, this is the case for most of the conditions, as shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}. For sortase-mediated ligation at 2 μM GGG-*EGF*, a maximal amount of 19 pmol of GGG-*EGF* was found to be cleaved from hydrogels ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A), equivalent to the 20 pmol obtained from quantification of depletion from the original reaction solution with a sandwich ELISA after the reaction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A). Further, this suggests that at this nucleophile concentration, all the consumed GGG-*EGF* is tethered to the hydrogel with imperceptible nonspecific binding. At 20 μM GGG-*EGF* initial concentration, a maximal amount of ∼160 pmol released GGG-*EGF* was detected, for hydrogels with 250 μM *LPRTG*-gel ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B). This means that from the estimated 230 pmol GGG-*EGF* that disappeared from the initial ligation reaction supernatant ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B), 160 pmol GGG-*EGF* was tethered to the hydrogel. Further, ∼11 pmol was recovered from washes (i.e, presumably partitioned into the aqueous phase of the hydrogel without binding), leaving a balance of 59 pmol that is presumably adsorbed to the hydrogel through noncovalent binding mechanisms ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B). Noncovalent binding, as estimated by the gap between the sum of the recovered material and that in original ligation solution, seems to be higher and more uniform relative to the *LPRTG*-gel concentration for the 20 μM GGG-*EGF* condition ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B).

![Nucleophile mass balance for sortase-mediated ligation of GGG-*EGF* to *LPRTG*-containing hydrogels as a function of *LPRTG* concentration in the hydrogel and for GGG-*EGF* concentrations of either 2 μM (A) or 20 μM (B). The amount of GGG-*EGF* present in initial tethering solution and in hydrogel supernatant after washes and after cleavage was quantified by sandwich ELISA. Error bars represent standard error of the mean (*n* = 2).](bm-2015-005498_0004){#fig4}

3.4. Direct ELISA Reveals Nonlinear Dependence of Surface-Tethered EGF on Substrate Concentration {#sec3.4}
-------------------------------------------------------------------------------------------------

The results of ELISA analysis on the reaction solutions ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) and the cleavage products ([Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) provide strong evidence for covalent sortase-mediated ligation of GGG-*EGF* to PEG hydrogels bearing the *LPRTG* motif, and suggest that the total amount of EGF tethered to the hydrogel is approximately proportional to the GGG-*EGF* concentration in the ligation solution. As the objective of tethering EGF to the hydrogels is to stimulate the EGF receptor of cells adhering to the hydrogel on a sustained basis, thus influencing downstream phenotypic responses, we further characterized the EGF tethered to the hydrogel using a direct ELISA approach to quantify the relative amounts of accessible EGF tethered under the different substrate conditions. Direct ELISA was conducted by incubating hydrogels with an anti-EGF antibody for 2 h, and thus it is expected that antibody binding would be restricted to near the surface of the hydrogels due to the slow diffusion of large proteins in the hydrogels. In this analysis, hydrogels incubated with GGG-*EGF* in the absence of sortase were included as a control for nonspecific binding.

The relative amounts of EGF detected by direct ELISA, as a function of initial *LPRTG*-gel concentration, GGG-*EGF* concentration in the ligation solution, and the presence or absence of sortase, are shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A as the net signal after subtraction of background. In agreement with the analysis presented in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, nonspecific interaction of GGG-*EGF* with the hydrogel is undetectable at the 2 μM GGG-*EGF* concentration, but is significant at the 20 μM GGG-*EGF* concentration, as evidenced by the detectable signal for hydrogels incubated with GGG-*EGF* in the absence of sortase, the lack of clear dependence of this signal on *LPRTG*-gel concentration, and the significant increase in the signal for hydrogels incubated with 20 μM compared to 2 μM GGG-*EGF* ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A). Interestingly, ELISA-detectable EGF increases with addition of sortase even in the absence of *LPRTG*-gel (i.e., comparison of the points along the vertical axis for *LPRTG*-gel = 0 μM in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A). The magnitude of this increase is comparable for the 2 μM and 20 μM GGG-*EGF* conditions. A plausible explanation is that sortase adsorbs nonspecifically to the hydrogels and acts as an affinity capture molecule for GGG-*EGF*.

![Detection of GGG-*EGF* on hydrogels as a function of total *LPRTG* concentration in hydrogel after sortase-mediated ligation of 2 or 20 μM GGG-*EGF*. (A) GGG-*EGF* nonspecific binding was tested after incubation of the hydrogels with 2 or 20 μM GGG-*EGF* in the absence of sortase. (B) Measurements performed without sortase were subtracted from the ones performed in the presence of the enzyme. Error bars represent standard error of the mean (*n* = 2).](bm-2015-005498_0005){#fig5}

In order to compare the relative amounts of EGF tethered to hydrogels via sortase-mediated ligation at different *LPRTG*-gel concentrations for the 2 and 20 μM GGG-*EGF* tethering concentrations, the signal associated with incubation in the absence of sortase was subtracted from the total signal for each *LPRTG*-gel concentration for the 2 μM and 20 μM GGG-*EGF* cases to normalize the data for nonspecific association of GGG-*EGF* with the hydrogels. The resulting values are plotted in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}B as a function of *LPRTG*-gel concentration initially present in the hydrogel. This plot shows that the net ELISA signal above background (including nonspecific adsorption) is roughly comparable at low (\<50 μM) *LPRTG*-gel concentrations for both the 2 μM and 20 μM GGG-*EGF* substrate conditions and at high (\>50 μM) *LPRTG-*gel concentrations, the net ELISA signal is about 2-fold greater for the 20 μM GGG-*EGF* than that for the 2 μM GGG-*EGF* condition. The difference in this result and the data in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, where measurement of cleaved EGF indicates a 10-fold greater amount of tethered EGF for the higher substrate concentration, can be interpreted in the context of the complex parallel rate processes occurring during the ligation reaction and during the direct ELISA. During reaction, both the substrate GGG-*EGF* and the sortase enzyme diffuse into the hydrogel, and the ligation reaction competes with a hydrolysis reaction in a manner such that hydrolysis is more prominent at very low GGG-*EGF* concentrations. Thus, it is likely that the ratio of tethered EGF for the two different substrate concentrations changes with distance from the surface of the hydrogel, such that the ratio of \[tethered EGF, 20 μM\] to \[tethered EGF, 2 μM\] increases away from the surface, due to the increase in prominence of hydrolysis in the 2 μM case.

3.5. DNA Synthesis of Primary Human Hepatocytes and Endometrial Epithelial Cells Is Enhanced by Tethered EGF {#sec3.5}
------------------------------------------------------------------------------------------------------------

The central objective of tethering EGF to PEG hydrogels is to present EGF in a mode that engages and activates the EGF receptor on the basal surface of adherent cells in a sustained fashion, and does so in the context of an environment that mimics key adhesion and mechanical features of extracellular matrix. Epithelial cells polarize EGFR and EGFR ligands to the basolateral surface, and disruption of this polarization is associated with disease states.^[@ref39]^ Some ligands for EGFR, such as amphiregulin, are strongly matrix binding and may act as pseudotethered ligands, hence presentation of EGF tethered to PEG hydrogels may mimic a mode of natural stimulation that is deficient in synthetic matrix. We thus focused on assessing the DNA synthesis response of primary epithelial cells to tethered EGF as proof-of-principle for the activity of tethered EGF.

Motivated in part by several studies showing the phenotypic effects of soluble versus tethered EGF on primary hepatocytes,^[@ref40]−[@ref42]^ we examined the DNA synthesis response of primary human hepatocytes as a metric of tethered EGF activity. We also investigated the DNA synthesis response of primary human endometrial epithelial cells, which express EGFR and respond to EGF stimulation.^[@ref43]^ Expansion and differentiation of primary human endometrial epithelial cells in culture is of great interest for study of endometrial biology and disease. Primary human hepatocytes and primary human endometrial epithelial cells are also representative of epithelial cells that are responsive to EGF but relatively refractory toward in vitro proliferation.

For these proof of principle experiments, we aimed to choose an EGF concentration in a regime that would be expected to maximally stimulate DNA synthesis, as human hepatocytes and endometrial epithelial cells exhibit relatively low rates of DNA synthesis and growth in vitro compared to cell lines and other more highly proliferative primary cell types such as mesenchymal stem cells and keratinocytes. The anticipated low rates of DNA synthesis under optimal conditions is further compounded by the potential for the PEG adhesion environment to further diminish the DNA synthesis response capacity of EGF-stimulated cells: even cells that proliferate robustly in response to EGF culture can exhibit diminished proliferation behaviors when the adhesion context is altered by the presence of relatively poorly adsorptive PEG chains. For example, in the challenging application of PDMS surface modification with PEG-tethered EGF for creation of a confluent corneal epithelial cell monolayer for a biohybrid cornea replacement, tethered EGF improved cell coverage but the PEG chains impeded complete, homogeneous monolayer formation.^[@ref44]^ We have also observed that DNA synthesis by primary rat hepatocytes cultured on glass substrates with PEG-tethered EGF is diminished when the PEG brush inhibits attachment of adhesion proteins^[@ref40]^ and that tethered EGF improves, but does not completely rescue, colony formation by primary human bone marrow stromal cells cultured on PEG-tethered minimal adhesion peptides compared to untreated glass.^[@ref45]^

Given that hydrogels tethered in the presence of 2 μM GGG-*EGF* exhibited undetectable (\<0.5 pmol) noncovalently bound EGF and presented abundant surface-accessible EGF ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A), we used a tethering concentration of 2 μM GGG-*EGF* with hydrogels containing 250 μM *LPRTG*-gel. This concentration ensures that observed effects were due to tethered EGF and not to noncovalently bound EGF leaching off the hydrogel. Further, based on our previous estimates of tethered ligand density required to stimulate maximal rates of DNA synthesis in hepatocytes,^[@ref40]^ the ligand density in such hydrogels was anticipated to be sufficient to stimulate maximal EGFR signaling on these epithelial cells. Specifically, at bulk concentrations of 250 μM, the LPRTG motif is spaced 19 nm apart on average, yielding an approximate surface density of about 2500 LPRTG/ μm^2^. EGF is tethered to yield a final average bulk concentration of 2 μM (20 pmol for 10 μL hydrogel, data from [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), resulting in an average spacing between EGF of about 95 nm and average of ∼100 EGF/ μm^2^. However, the surface appears to be somewhat enriched for tethered EGF than the bulk, thus we can estimate that cells spread to a typical size of 1000 μm^2^ are exposed to a lower limit of 100 000 and an upper limit of 2 500 000 molecules of EGF (the latter presumed all surface LPRTG are modified by EGF); i.e., comparable to or in excess of the number of cell surface receptors.

During the hydrogel fabrication process, hydrogels were functionalized with a branched peptide containing the PHSRN and RGD sequences derived from the 9th and 10th type III repeats in fibronectin. The canonical RGD motif from the 10th domain interacts primarily with α~v~ integrins and induces mesenchymal-like behavior in epithelial cells, while inclusion of the 9th domain PHSRN synergy site fosters interactions through integrin α~5~β~1~ and a more physiological phenotypic response.^[@ref46]^ The *synKRGD* sequence^[@ref47]^ was incorporated into hydrogels via Michael-type addition through the thiol on the GGGERCG segment at the time of initial hydrogel synthesis to give a concentration of 0.5 mM, as we observed in pilot studies that this concentration was sufficient to induce robust attachment of the epithelial cell types used in this study.

Human primary hepatocytes and endometrial epithelial cells were cultured on hydrogels containing 0 or 500 μM *synKRGD* adhesion peptide. Because the presence of the adhesion peptide during cross-linking may influence the structure of the hydrogels, we substituted peptides with scrambled adhesion sequences (see [Experimental Section](#sec2){ref-type="other"}) for the active *synKRGD* to create the control "0 μM *synKRGD*" peptide condition. Cells were either unexposed to EGF, presented with EGF tethered at 2 μM on 250 μM *LPRTG*-gel hydrogels, or presented with soluble hEGF at a concentration of 20 ng/mL (3.3 nM). The *K*~D~ for EGF binding to EGFR is 0.2--1 nM,^[@ref40]^ and the DNA synthesis response is saturated at soluble EGF values \>3 nM.^[@ref48]^ DNA synthesis was assessed over a period of 24h, 48 h after seeding for hepatocytes and 40 h after seeding for endometrial epithelial cells.

In the absence of EGF, while only a small number of cells attached to hydrogels containing 500 μM scrambled adhesion peptide ("0 μM *synKRGD*"), cell attachment on 500 μM active *synKRGD* hydrogels was comparable to positive controls on collagen I or TCPS ([Figures [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A and C). Tethered EGF had no effect on hepatocyte attachment, contrary to soluble hEGF, which slightly enhanced attachment on 500 μM *synKRGD* hydrogels compared to unexposed hydrogels, and which yielded a 1.8 fold increase on collagen I-coated TCP ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A). In contrast, tethered EGF was as effective as the soluble form in fostering endometrial epithelial cell attachment to 0 and 500 μM *synKRGD* hydrogels ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}C), and soluble EGF substantially enhanced endometrial epithelial cell attachment on standard TCPS ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}C).

![Cell attachment and DNA synthesis of primary human hepatocytes (A, B) and endometrial epithelial cells (C, D). Cells were seeded on hydrogels containing 0 or 500 μM *synKRGD* and 250 μM *LPRTG* and on standard culture substrates. After 48 h (A, B) or 40 h in culture (C, D), cells were incubated with 10 μM EdU for 24 h. Tethered EGF stimulated DNA synthesis compared to unmodified hydrogels or soluble h*EGF*. Error bars represent standard error of the mean (*n* = 3).](bm-2015-005498_0006){#fig6}

Additionally, soluble EGF considerably increased DNA synthesis of primary hepatocytes compared to control cultures without EGF, from 9 to 21% on 500 μM *synKRGD* hydrogels and from 10 to 22% on collagen I-coated TCPS ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B). Stimulation of hepatocyte DNA synthesis by tethered EGF tended to be slightly greater: from 9 to 27% on 500 μM *synKRGD* hydrogels ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B). In previous studies of primary rat hepatocytes on EGF tethered to glass^[@ref40]^ or to self-assembling peptides hydrogels,^[@ref41]^ DNA synthesis rates stimulated by tethered EGF were comparable to or slightly lower than rates stimulated by a saturating amount of soluble EGF on hydrogels or on collagen-coated tissue culture plastic. Human hepatocytes have previously been reported to exhibit a lower rate of DNA synthesis than rat hepatocytes when stimulated by soluble EGF,^[@ref49]^ hence, the enhanced DNA synthesis response here for EGF tethered to *synKRGD*-modified hydrogels, compared to stimulation by soluble EGF of hepatocytes on either *synKRGD*-modified hydrogels or collagen I-coated substrates, may reflect a species difference. It may also arise from a more favorable combination of adhesion and EGFR signaling than was achievable in the glass-tethered or peptide-gel-tethered format. Primary endometrial epithelial cells also responded to soluble EGF stimulation by increasing DNA synthesis, from 6 to 12% on 500 μM *synKRGD* hydrogels and from 6 to 15% on TCPS ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}D). The effect of tethered EGF was comparable to that of soluble EGF in these cells, increasing DNA synthesis from 6 to 14% compared to control hydrogels ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}D).

These results provide encouraging evidence that EGF tethered to functionalized PEG hydrogels via sortase-mediated ligation stimulates biologically relevant responses in primary human epithelial cells. This study thus provides a foundation for future analysis of more detailed phenotypic responses.

4. Conclusions {#sec4}
==============

In conclusion, we report sortase-mediated ligation of human EGF to preformed PEG hydrogels. This enzymatic approach is not only simple and relatively inexpensive, but it also displays high specificity and modularity, and may be applied to a variety of PEG hydrogels including those cross-linked in situ in the presence of cells. A compendium of analytical approaches were used to show that the amount of grafted growth factor was readily controlled by the amount of *LPRTG* substrate incorporated in hydrogels and the amount of GGG-*EGF* present in solution. While the sortase enzyme was capable of recognizing and processing *LPRTG* peptides that were incorporated in the hydrogels through Michael-type addition, this method represents a useful tool for specific modification of any type of hydrogel containing the appropriate substrate. The results of this study underscore the challenges in interpreting reaction data for preformed hydrogels, as the combination of kinetic and diffusion phenomena working in concert during the ligation process may create gradients of enzyme and substrate in the hydrogels; indeed, here, the growth factor appeared to be somewhat enriched at the surface of the hydrogels. This study also underscores the challenges in minimizing noncovalent binding during such tethering processes, as even with the well-established antifouling properties of the PEG polymer as well as enzymatic specificity, significant nonspecific binding appeared to occur for high GGG-*EGF* coupling concentration. One of the more novel aspects of the study is the exploitation of sortase as a cleavage enzyme. Efficient and near complete release of tethered EGF from the hydrogels through sortase-catalyzed reaction of the *LPRTG*-containing tether with soluble GGG allows near absolute quantification of the previous tethered protein through well-established solution phase techniques. Finally, biological activity of the tethered EGF was confirmed by the phenotypic response of human primary epithelial cells. The well-studied hepatocyte cell system showed a more robust enhancement to tethered EGF (compared to soluble EGF) than had been observed in previously published studies, while preliminary experiments with endometrial epithelial cells constituted a first example of endometrial epithelial cell culture in the presence of a tethered growth factor. This demonstration of sortase-mediated ligation of bioactive molecules to hydrogels will likely contribute to the development of improved culture systems for in vitro models, by expanding the repertoire of bioactive molecules that can be covalently attached to PEG to include large peptides and proteins.

Protocol for primary human epithelial cells isolation and purification; (S1) standard curve for conversion of hydrogel fluorescence arbitrary units to amount of *LPRTG* in pmol; (S2) photobleaching controls; (S3) percentage of retained hydrogel fluorescence as a function of *LPRTG* in hydrogel after sortase-mediated hydrogel cleavage; (S4) micrographs of hepatocyte DNA synthesis on tethered EGF hydrogels; (S5) micrographs of endometrial epithelial cell DNA synthesis on tethered EGF hydrogels. The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acs.biomac.5b00549](http://pubs.acs.org/doi/abs/10.1021/acs.biomac.5b00549).
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